Economic Evaluation Seminar - Cost-effectiveness of implantable cardioverter defibrillator for the primary prevention of patients post myocardial infarction

About the speaker

Yirui Qian, Research Fellow, Centre for Health Economics

Yirui Qian is a Research Fellow in the Economic Evaluation and Health Technology Assessment (TEEHTA) theme. She holds a MSc in Health Economics and Decision Modelling and a PhD that focuses on multiple statistical methods for the analysis of patient-reported outcomes in randomised controlled trials, both of which were obtained the from University of Sheffield.

Yirui’s research interests include the application of statistical methods for analysing health outcomes particularly patient-reported outcomes, cost-effectiveness analysis alongside trials, and decision analytic models. Yirui is also interested in a range of broad topics related to health economics modelling, including computationally intensive simulation, public health economic evaluation, approaches to incorporating social values (such as equity) into the process of health technology assessment and health benefit package design.

Yirui currently works on two projects: the health economic modelling for the PRevention Of sudden cardiac death aFter myocardial Infarction by Defibrillator implantation (the PROFID EHRA project) that reassesses the risk-benefits of implantable cardioverter-defibrillator in addition to optimal medical therapy; and the Healthy Urban Places (HUP-North) that aims to understand how to harness the power of local places to improve population health and reduce inequalities. Previously, Yirui worked on  the Health Financing Universal Health Care in Challenging Times (HFACT project), where she developed her knowledge sets in bring social values into the HTA process using advanced method such as distribution cost-effectiveness analysis and cross-sectoral impact inventory.